The results of screening for prostate cancer in men aged up to 55 years
- 作者: Tarend D.1, Sukonko O.2, Krasny S.2, Semenov S.2, Karman A.2
-
隶属关系:
- Minsk Regional Clinical Hospital
- N.N. Alexandrov National Cancer Centre
- 期: 卷 21, 编号 1-2 (2016)
- 页面: 47-50
- 栏目: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40309
- DOI: https://doi.org/10.18821/1028-9984-2015-21-1-47-50
- ID: 40309
如何引用文章
全文:
详细
作者简介
D. Tarend
Minsk Regional Clinical HospitalMinsky distr., 223041, Belarus
O. Sukonko
N.N. Alexandrov National Cancer CentreMinsk, 223040, Belarus
S. Krasny
N.N. Alexandrov National Cancer CentreMinsk, 223040, Belarus
Svyataslau Semenov
N.N. Alexandrov National Cancer Centre
Email: SemenovSv3@gmail.com
urologist, Department of the urology Minsk, 223040, Belarus
A. Karman
N.N. Alexandrov National Cancer CentreMinsk, 223040, Belarus
参考
- Океанов А.Е., Моисеев П.И., Левин Л.Ф. Статистика онкологических заболеваний в Республике Беларусь (2004-2013). Минск: РНПЦ ОМР им. Н.Н. Александрова; 2014.
- Океанов А.Е., Моисеев П.И., Красный С.А., Поляков С.Л., Евмененко А.А. Рак предстательной железы в Республике Беларусь. Онкологический журнал. 2012; 1: 15-24.
- Суконко О.Г., Красный С.А., Океанов А.Е., Моисеев П.И., Поляков С.Л. Рак предстательной железы в Республике Беларусь: вчера, сегодня, завтра. Здравоохранение. 2013; 11: 34-42.
- Heidenreich A., Abrahamsson P., Artibani W., Catto J., Montorsi F., Van Poppel H. et al. Early detection of prostate cancer: european association of urology recommendation. Eur. Urol. 2013; 64 (3): 347-54.
- Antenor J.A., Han M., Roehl K.A., Nadler R.B., Catalona W.J. Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study. J. Urol. 2004; 172: 90-3.
- Takechi H., Ito K., Yamamoto T., Ohi M., Kubota H. Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less. Prostate. 2003; 57: 8-13.
- Roobol M.J., Roobol D.W., Schröder F.H. Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/ml or less in a population-based screening setting? (ERSPC, section Rotterdam). Urology. 2005; 65: 343-6.